Hypertrophic cardiomyopathy+1
RecruitingA study testing ninerafaxstat compared to placebo in patients with symptomatic non-obstructive hypertrophic cardiomyopathy
A study testing ninerafaxstat compared to placebo in patients with symptomatic non-obstructive hypertrophic cardiomyopathy
- Disease:Hypertrophic cardiomyopathyCardiomyopathy
- Substances:Ninerafaxstat trihydrochloride monohydrate
Italy- Participants:18–64 years · 65+ years
- Substances:Ninerafaxstat trihydrochloride monohydrate
- Sponsor:Imbria Pharmaceuticals Inc.



